No black box warning on record for Clobezin

As of the latest FDA labeling reviewed, Clobezin (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE, ZINC OXIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Clobezin medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Clotrimazole and betamethasone dipropionate cream can cause reversible HPA axis suppression with the potential for glucocorticosteroid insufficiency during and after withdrawal of the treatment. Risk factor(s) are: use of high-potency topical corticosteroid, use over a large surface area or to areas under occlusion, prolonged use, altered skin barrier, liver failure, and

No black box warning on record for Clobezin

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Clotrimazole and betamethasone dipropionate cream can cause reversible HPA axis suppression with the potential for glucocorticosteroid insufficiency during and after withdrawal of the treatment. Risk factor(s) are: use of high-potency topical corticosteroid, use over a large surface area or to areas under occlusion, prolonged use, altered skin barrier, liver failure, and

Clobezin Black Box Warning

No black box warning on record for Clobezin

Other warnings & precautions

Clobezin Black Box Warning

No black box warning on record for Clobezin

Other warnings & precautions